Farnesol exerts protective effects against chronic sleep deprivation-induced cognitive impairment via activation SIRT1/Nrf2 pathway in the hippocampi of adult mice.

Zheng Xie,Ailin Luo,Yue Wang,Xiaoxiao Luo,Zhi-qiang Zhou,Dongyu Hua,Xuan Wang,Yujuan Li,Shiyong Li,R. Sun,Mingke Guo
DOI: https://doi.org/10.1002/mnfr.202200735
IF: 6.5749
2023-03-29
Molecular Nutrition & Food Research
Abstract:SCOPE Sleep deprivation (SD) negatively affects all aspects of health, with one serious consequence being impaired cognition. Farnesol (FOL) is a sesquiterpene synthesized by plants and mammals that has antioxidant, anti-inflammatory, and neuroprotective properties. This study investigated the mechanism of action of FOL on SD-induced cognitive impairment. METHODS AND RESULTS Administration of FOL dramatically ameliorated chronic sleep deprivation (CSD)-induced cognitive impairment. In addition, FOL notably attenuated oxidative stress damage, pro-inflammatory cytokines activation, and microglial activation in the hippocampi of the CSD-exposed mice. Further examination indicated that administration of FOL after the CSD significantly increased the protein expressions of silent information regulator factor 2-related enzyme 1 (Sirt1), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and glutathione peroxidase 4 (Gpx4) in the hippocampi. Sirt1 agonist resveratrol (RES) had a similar neuroprotective effect, indicating that FOL could exsert neuroprotective effects through the activation of the Sirt1/Nrf2 signaling pathway. CONCLUSION The results revealed that FOL could protect against CSD-induced cognitive impairment by activating the Sirt1/Nrf2 signaling pathway. This article is protected by copyright. All rights reserved.
Medicine,Environmental Science
What problem does this paper attempt to address?